CATALYST PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": 41303000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | CATALYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/48cd6973-139c-43ed-908d-64e670a5ce15
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-077228Retrieved: 2026-08-19T13:07:58.514226+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001369568/operating-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/48cd6973-139c-43ed-908d-64e670a5ce15
History
- supersedes {"amount": 41303177, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001193125-21-081545)